/education-service/media/default/55038/9c7f3b34.png)
Implant Placement in High-Risk Patients for Jaw Necrosis
/filters:format(webp)/education-service/media/default/55023/903b1f37.jpg)
Robert Marx
Detalhes do curso
Palestrante
/education-service/media/default/55038/9c7f3b34.png)
53m
Aula
Implant Placement in High-Risk Patients for Jaw Necrosis
Robert Marx/education-service/media/default/55027/fa75b64e.png)
/education-service/media/default/19187/ad155962.jpg)
/education-service/media/default/29759/ec9aafdd.jpg)
/education-service/media/default/42683/d7a9357e.jpg)
/education-service/media/default/45394/a3c14489.jpg)
/education-service/media/default/63465/5ceca3ee.webp)
/education-service/media/default/25295/f112071a.jpg)
/education-service/media/default/48105/71820892.jpg)
/education-service/media/default/44498/dd1970bf.jpg)
Detalhes
Programa de aula
– Difference between the implant risk of Drug Induced Osteonecrosis of the Jaws (DIONJ) vs. Osteoradionecrosis (ORN)
– The proven value of drug holidays for patients at risk for DIOJ
– Progressive risk for ORN over time
– Accepted protocols for Hyperbaric Oxygen Therapy (HBOT) to reduce the risk for ORN
– Application of Hyperbaric Oxygen and Pentoxifylline to reduce the risk for ORN and analysis of the clinical results
– Exploration of adjunctive therapies for managing DIONJ and ORN
– Review of case studies illustrating successful management strategies for DIONJ and ORN.
Recommended for: Implantologists, Oral and maxillofacial surgeons, General dentists.